Oksana has negotiated complex commercial agreements, developed IP and marketing strategies for a variety of technologies, facilitated commercial exploitation of early-stage assets, and concluded multiple deals. She has solid expertise in evaluation of companies and technologies (with the focus in oncology, ophthalmology, inflammation and neurology), building financial models and forecasts as well as IP management. She is a great team player with strong communication skills and superb work ethic. Oksana has made significant contributions to her organizations in her previous roles. She holds a PhD in oncology and an MBA with specialization in biotechnology management.